MedPath

Study held to see the effect of Dashamooladi tablet in tingling sensation and/or numbness

Phase 2
Conditions
Health Condition 1: G909- Disorder of the autonomic nervoussystem, unspecified
Registration Number
CTRI/2023/02/049994
Lead Sponsor
Dr Bhavya Khurana
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Age between 18-70 years of both genders.

2) Patients with the symptoms of tingling sensation and/or numbness.

3) Patients who are not taking any other medications for tingling sensations and/or numbness.

Exclusion Criteria

1) Known pregnant and lactating woman.

2) Patients with Pulmonary Tuberculosis , Cardiac complications, Immuno-compromised, Renal complications, Malignancies etc.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To access the effect of Dashamooladi Ghanavati in the management of Jhinjhini VataTimepoint: 14 days study with 2 follow ups (0,7,14)
Secondary Outcome Measures
NameTimeMethod
1) To study the new etiological factors of Jhinjhini Vata in present era. <br/ ><br>2) To study the ayurvedic pathogenesis of Jhinjhini Vata.Timepoint: 14 days study with 2 follow ups (0,7,14)
© Copyright 2025. All Rights Reserved by MedPath